search icon
      blog search icon

      LYEL Stock Price History and Quote Analysis: Insights for Investors

      Lyell Immunopharma, Inc.



      -0.02 (-1.03%)

      At Close: 4:00 PM

      LYEL Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      LYEL Stock Price Today

      Lyell Immunopharma, Inc. (LYEL) stock rallied over 2.13% intraday to trade at $1.92 a share on NASDAQ. The stock opened with a loss of -14.95% at $1.65 and touched an intraday high of $1.65, falling -1.03% against the last close of $1.94. The Lyell Immunopharma, Inc. in stock market went to a low of $1.57 during the session.

      LYEL Stock Snapshot


      Prev. Close

      483.59 Million

      Market Cap


      Day Low




      Number of Shares


      Day High


      P/E ratio


      EPS (TTM)


      Cash Flow per Share


      Free Float in %


      Book Value



      LYEL Stock Price History Chart


      Contact Details

      201 Haskins Way
      South San Francisco, CA 94080


      Contact #:650 695 0677

      Company Information



      Sales or Revenue$48.5 Million

      5Y Sales Change604.33%

      Fiscal Year EndsDec. 2022



      About Company

      Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


      Frequently Asked Questions


      What is the current Lyell Immunopharma, Inc. (LYEL) stock price?

      Lyell Immunopharma, Inc. (NASDAQ: LYEL) stock price is $1.92 in the last trading session. During the trading session, LYEL stock reached the peak price of $1.65 while $1.57 was the lowest point it dropped to. The percentage change in LYEL stock occurred in the recent session was 2.13% while the dollar amount for the price change in LYEL stock was $0.04.


      LYEL's industry and sector of operation?

      The NASDAQ listed LYEL is part of Biotechnology industry that operates in the broader Healthcare sector. Lyell Immunopharma, Inc. , a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors.


      Who are the executives of LYEL?

      Ms. Elizabeth Homans
      Chief Executive Officer & Director
      Dr. Lynn Seely M.D., Ph.D.
      Pres, Chief Executive Officer & Director
      Ellen Rose
      Vice President of Communications & Investor Relations
      Mr. Richard Goold Ph.D.
      Chief Information Officer


      How LYEL did perform over past 52-week?

      LYEL's closing price is 0.37% higher than its 52-week low of $1.32 where as its distance from 52-week high of $6.18 is -0.72%.


      How many employees does LYEL have?

      Number of LYEL employees currently stands at N/A. LYEL operates from 201 Haskins Way, South San Francisco, CA 94080, US.


      Link for LYEL official website?

      Official Website of LYEL is:


      How do I contact LYEL?

      LYEL could be contacted at phone #650 695 0677 and can also be accessed through its website. LYEL operates from 201 Haskins Way, South San Francisco, CA 94080, US.


      How many shares of LYEL are traded daily?

      LYEL stock volume for the day was 862109.00 shares. The average number of LYEL shares traded daily for last 3 months was 920.81 Thousands.


      What is the market cap of LYEL currently?

      The market value of LYEL currently stands at $483.59 Million with its latest stock price at $1.92 and N/A of its shares outstanding.